Glucose metabolic reprogramming in autoimmune diseases
ABSTRACTAutoimmune diseases are conditions in which the immune system mistakenly targets and damages healthy tissue in the body. In recent decades, the incidence of autoimmune diseases has increased, resulting in a significant disease burden. The current autoimmune therapies focus on targeting infla...
Main Authors: | Hoim Jeong, Beomgu Lee, Seung Jin Han, Dong Hyun Sohn |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Animal Cells and Systems |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19768354.2023.2234986 |
Similar Items
-
Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis
by: Chen Huang, et al.
Published: (2021-08-01) -
Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
by: Kishor Pant, et al.
Published: (2020-04-01) -
Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
by: Pengzhu Huang, et al.
Published: (2023-02-01) -
Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance
by: Rong Qin, et al.
Published: (2024-12-01) -
LncRNA TUG1 mediates microglial inflammatory activation by regulating glucose metabolic reprogramming
by: Chunxiang He, et al.
Published: (2024-05-01)